Sciclone Pharmaceut (SCLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 160,096 | 157,257 | 134,790 | 127,058 | 156,269 |
| Cost of Goods | 22,898 | 22,348 | 23,002 | 17,668 | 21,996 |
| Gross Profit | 137,198 | 134,909 | 111,788 | 109,390 | 134,273 |
| Operating Expenses | 104,861 | 105,346 | 85,806 | 99,629 | 128,859 |
| Operating Income | 33,235 | 29,911 | 25,984 | 10,429 | 6,410 |
| Interest Expense | 0 | 0 | 48 | 103 | 185 |
| Other Income | 898 | 359 | 441 | 2,880 | 47 |
| Pre-tax Income | 34,133 | 30,270 | 26,377 | 13,206 | 6,272 |
| Income Tax | 3,404 | 807 | 1,169 | 2,242 | -3,348 |
| Net Income Continuous | 30,729 | 29,463 | 25,208 | 10,964 | 9,620 |
| Net Income | $30,729 | $29,463 | $25,208 | $10,964 | $9,620 |
| EPS Basic Total Ops | 0.61 | 0.59 | 0.49 | 0.20 | 0.17 |
| EPS Basic Continuous Ops | 0.61 | 0.59 | 0.49 | 0.20 | 0.17 |
| EPS Diluted Total Ops | 0.58 | 0.56 | 0.48 | 0.20 | 0.16 |
| EPS Diluted Continuous Ops | 0.58 | 0.56 | 0.48 | 0.20 | 0.16 |
| EPS Diluted Before Non-Recurring Items | 0.71 | 0.91 | 0.69 | 0.35 | 0.56 |
| EBITDA(a) | $34,220 | $30,842 | $26,836 | $11,289 | $9,859 |